Healthcare & Life Sciences
Strand AI
United States
series-b
series-b
Stage
1
Investors
About
Strand AI develops multimodal biological foundation models to impute missing patient biodata, including spatial biology data, enabling pharmaceutical companies to better select clinical trial participants and accelerate drug development timelines.
Explore Strand AI's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.